Slingshot members are tracking this event:
Merck (MRK) and Pfizer (PFE) Announce Phase 3 Results for Type 2 Diabetes Candidate Ertugliflozin
Slingshot Insights Explained
Sep 15, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Clinical Results, Vertis Sita2, Ertugliflozin